1 |
Ivanova J, Abdoli M, Nocentini A, Žalubovskis R, Supuran CT. Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II. J Enzyme Inhib Med Chem 2023;38:2170370. [PMID: 36718988 DOI: 10.1080/14756366.2023.2170370] [Reference Citation Analysis]
|
2 |
Mahapatra M, Mekap SK, Mal S, Sahoo J, Sahoo SK, Paidesetty SK. Coumaryl-sulfonamide moiety: Unraveling their synthetic strategy and specificity toward hCA IX/XII, facilitating anticancer drug development. Arch Pharm (Weinheim) 2023;:e2200508. [PMID: 36587981 DOI: 10.1002/ardp.202200508] [Reference Citation Analysis]
|
3 |
Ivanova J, Abdoli M, Nocentini A, Žalubovskis R, Supuran CT. 1,2,3-Benzoxathiazine-2,2-dioxides – effective inhibitors of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry 2023;38:225-238. [DOI: 10.1080/14756366.2022.2142787] [Reference Citation Analysis]
|
4 |
Al-Warhi T, Elbadawi MM, Bonardi A, Nocentini A, Al-Karmalawy AA, Aljaeed N, Alotaibi OJ, Abdel-Aziz HA, Supuran CT, Eldehna WM. Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. J Enzyme Inhib Med Chem 2022;37:2635-43. [PMID: 36146927 DOI: 10.1080/14756366.2022.2124409] [Reference Citation Analysis]
|
5 |
Azeez RFA, Zara S, Ricci A, Dev S, Vengamthodi A, Kavully FS, Abdu RA, Kalathil KT, Abdelgawad MA, Mathew B, Carradori S. Integrating N-alkyl amide in the chalcone framework: synthesis and evaluation of its anti-proliferative potential against AGS cancer cell line. Res Chem Intermed 2022. [DOI: 10.1007/s11164-022-04864-w] [Reference Citation Analysis]
|